EUVIMEDEUVIMED entdecken
Crossref

20( S )‐ Protopanaxadiol saponins isolated from Panax notoginseng target the binding of HMGB1 to TLR4 against inflammation in experimental ulcerative colitis

Jinfen Chen, Pengde Lu, Jiayue Liu iD, Li Yang, Yiyang Li, Yanling Chen, Yitao Wang, Jianbo Wan, Yonghua Zhao iD

Phytotherapy Research · 2023-10 · 37 (10) · 4690-4705

DOI: 10.1002/ptr.7938 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Phytotherapy Research, online erschienen am 09.07.2023. Verfasst von Jinfen Chen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Chinese Medical Sciences, State Key Laboratory of Quality Research in Chinese Medicine, University of Macau, Taipa, Macao SAR, China. Hauptthemen laut MEDLINE: Colitis, Ulcerative, Saponins, Panax notoginseng, HMGB1 Protein. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: 2020 Guangdong Provincial Science and Technology Innovation Strategy Special Fund, Fundo para o Desenvolvimento das Ciências e da Tecnologia, Universidade de Macau.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ulcerative colitis (UC) has emerged as a global healthcare issue due to high prevalence and unsatisfying therapeutic measures. 20( S )‐ Protopanaxadiol saponins (PDS) from Panax notoginseng with anti‐inflammatory properties is a potential anti‐colitis agent. Herein, we explored the effects and mechanisms of PDS administration on experimental murine UC. Dextran sulfate sodium‐induced murine UC model was employed to investigate anti‐colitis effects of PDS, and associated mechanisms were further verified in HMGB1‐exposed THP‐1 macrophages. Results indicated that PDS administration exerted ameliorative effects against experimental UC. Moreover, PDS administration remarkably downregulated mRNA expressions and productions of related pro‐inflammatory mediators, and reversed elevated expressions of proteins related to NLRP3 inflammasome after colitis induction. Furthermore, administration with PDS also suppressed the expression and translocation of HMGB1, interrupting the downstream TLR4/NF‐κB pathway. In vitro, ginsenoside CK and 20( S )‐protopanaxadiol, the metabolites of PDS, exhibited greater potential in anti‐inflammation, and intervened with the TLR4‐binding domain of HMGB1 predictably. Expectedly, ginsenoside CK and 20( S )‐protopanaxadiol administrations inhibited the activation of TLR4/NF‐κB/NLRP3 inflammasome pathway in HMGB1‐exposed THP‐1 macrophages. Summarily, PDS administration attenuated inflammatory injury in experimental colitis by blocking the binding of HMGB1 to TLR4, majorly attributed to the antagonistic efficacies of ginsenoside CK and 20( S )‐protopanaxadiol.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colitis, UlcerativeSaponinsPanax notoginsengHMGB1 ProteinColitisMiceAnimalsToll-Like Receptor 4NF-kappa BInflammasomesNLR Family, Pyrin Domain-Containing 3 ProteinInflammationAnti-Inflammatory AgentsDextran SulfateSapogeninsGinsenosides

Stichwörter der Autor:innen

20(S)-protopanaxadiol saponinsHMGB1TLR4inflammationulcerative colitis

Substanzen

SaponinsToll-Like Receptor 4NF-kappa BInflammasomesNLR Family, Pyrin Domain-Containing 3 ProteinHMGB1 ProteinAnti-Inflammatory AgentsDextran SulfateprotopanaxadiolSapogenins

Autor:innen und Institutionen

  • Institute of Chinese Medical Sciences, State Key Laboratory of Quality Research in Chinese Medicine, University of Macau, Taipa, Macao SAR, China.
  • Department of Pathophysiology, Zhuhai Campus of Zunyi Medical University, Zhuhai, Guangdong, China.
  • Guangdong-Hong Kong-Macau Joint Lab on Chinese Medicine and Immune Disease Research, University of Macau, Taipa, Macao SAR, China.

ORCID-Profile: Jiayue Liu, Yonghua Zhao

Förderung

  • 2020 Guangdong Provincial Science and Technology Innovation Strategy Special Fund
  • Fundo para o Desenvolvimento das Ciências e da Tecnologia
  • Universidade de Macau

Zitieren

APA

Chen, J., Lu, P., Liu, J., Yang, L., Li, Y., Chen, Y., Wang, Y., Wan, J., & Zhao, Y. (2023). 20( S )‐ Protopanaxadiol saponins isolated from Panax notoginseng target the binding of HMGB1 to TLR4 against inflammation in experimental ulcerative colitis. Phytotherapy Research, 37(10), 4690-4705. https://doi.org/10.1002/ptr.7938

Vancouver

Chen J, Lu P, Liu J, Yang L, Li Y, Chen Y, et al. 20( S )‐ Protopanaxadiol saponins isolated from Panax notoginseng target the binding of HMGB1 to TLR4 against inflammation in experimental ulcerative colitis. Phytotherapy Research. 2023;37(10):4690-4705. doi:10.1002/ptr.7938

BibTeX
@article{Chen2023,
  author = {Chen, Jinfen and Lu, Pengde and Liu, Jiayue and Yang, Li and Li, Yiyang and Chen, Yanling and Wang, Yitao and Wan, Jianbo and Zhao, Yonghua},
  title = {20( S )‐ Protopanaxadiol saponins isolated from Panax notoginseng target the binding of HMGB1 to TLR4 against inflammation in experimental ulcerative colitis},
  journal = {Phytotherapy Research},
  year = {2023},
  volume = {37},
  number = {10},
  pages = {4690--4705},
  doi = {10.1002/ptr.7938}
}
Kostenlos starten →